Other News

The BioMed Alliance through the work of its Task Force “Clinical Trials” published a statement on the need for Europe to implement patient-centered clinical research.     Precision medicine approaches the treatment of disease via an individual’s genes, environment, and… Continue Reading

            by Anna Sauerbier         EFNA’s Survey of Young Europeans with Neurological Conditions https://www.efna.net/wp-content/uploads/2018/07/EFNAYoungPeopleSurvey.pdf   Two years after Brexit vote, a cloud still hangs over research https://sciencebusiness.net/news/two-years-after-brexit-vote-cloud-still-hangs-over-research   Societal Impact of Pain… Continue Reading

Biomed Alliance: Prof. Axel Pries, President of the Biomed Alliance, meets with MEP Christian Ehler, rapporteur to the EP for the EC Horizon Europe Framework.   In view of the ongoing political discussions around the European Commission’s proposal for funding… Continue Reading

                                                 Thanks to a memorandum of understanding between the European academy of neurology (EAN) and the African academy of neurology (AFAN), for the second year, AFAN has had an exhibition stand at the EAN congress; this year in Lisbon, Portugal.… Continue Reading

Last week marked the launch of the EBC statement “Counting down to zero: Towards a future with underfunded health research?”, which calls on the European Commission, the European Parliament and the Council of the European Union to increase the budget of the 9th Framework Programme of Research & Innovation, or “Horizon Europe”, to at least €120 billion.

Prof. F. Fazekas, President of the EAN and Prof. W. Struhal President of EFAS are pleased to announce that: EAN has joined with EFAS to promote Autonomic Nervous System (ANS) disorders in Europe and advance optimal care and management for… Continue Reading

EFNA member association Dystonia Europe was among the winners of the Brain, Mind, and Pain Patient-Centred Innovation Grant, announced on Wednesday in Brussels.

GAMIAN-Europe, a patient-driven pan-European organization, represents the interests of persons affected by mental illness and advocates their right www.gamian.eu   GAMIAN Europe: European Parliament Interest Group on Mental Health, Well-being and Brain Disorders European Parliament, Brussels, Belgium, 16 May 2018… Continue Reading

On the occasion of the ninth European Conference on Rare Diseases & Orphan Products (ECRD) held in Vienna on 10th-12th May 2018, Prof. Marc Dooms, main author of the Declaration on Good Off-Label Use Practices (GOLUP), presented the 5 criteria for using medicines off-label that are laid down in the declaration. Many participants showed an interest in the declaration as well as various initiatives organized within the framework of the GOLUP-campaign.

WFN website: www.wfneurology.org Adress for the WBD: wbd2018@wfneurology.org. Clean air for brain health Mohammad Wasay MD, FRCP, FAAN (Aga Khan University, Karachi, Pakistan)
Wolfgang Grisold MD (Secretary General, WFN, Vienna, Austria) A link between environment and health has long been… Continue Reading

Last week EFNA attended the 4th European Academy of Neurology (EAN) Congress in Lisbon, along with more than 6700 neurologists! Once again, EFNA took this opportunity to bring together our members for our annual General Assembly. On Day 1 we… Continue Reading

        by Anna Sauerbier         Digital medicine and treatment development for brain disorders AZ, Lilly pull plug on Alzheimer’s disease trials France builds first Alzheimer’s ‘village’ in pioneering experiment Horizon Europe budget not big… Continue Reading

Prof. G. Deuschl, President of the EAN and Prof. W. Wick President of EANO are pleased to announce that: EAN has joined with EANO to promote optimal management of neuro-oncological care in neurology in Europe.

Dear Colleague, We seek your help in identifying candidates for the € 1 million prize, The Brain Prize, which is awarded by the Lundbeck Foundation. The Brain Prize recognizes highly original and influential advances in research on the nervous system,… Continue Reading

David B. Vodušek (DBV): Mr Bundgaard-Nielsen, you have been director of the Lundbeck Foundation. Can you explain to our readers the facts about this foundation and its relations to Lundbeck, the well known pharmaceutical company? Mogens Bundgaard-Nielsen (MBN): The Lundbeck Foundation was established in 1954 by Grete Lundbeck. She was the widow after Hans Lundbeck, the founder of the company H. Lundbeck who died some 10 years earlier. She eventually